Opus Genetics (IRD) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.67% |
| Dec 31, 2025 | 23.23% |
| Sep 30, 2025 | 32.53% |
| Jun 30, 2025 | 30.41% |
| Mar 31, 2025 | 33.05% |
| Dec 31, 2024 | 83.25% |
| Sep 30, 2024 | 21.94% |
| Jun 30, 2024 | 20.46% |
| Mar 31, 2024 | 21.69% |
| Dec 31, 2023 | 27.45% |
| Sep 30, 2023 | 31.32% |
| Jun 30, 2023 | 18.97% |
| Mar 31, 2023 | 15.02% |
| Dec 31, 2022 | 11.61% |
| Sep 30, 2022 | -9.94% |
| Jun 30, 2022 | -8.62% |
| Mar 31, 2022 | 0.91% |
| Dec 31, 2021 | 4.38% |
| Sep 30, 2021 | 0.40% |
| Jun 30, 2021 | 4.23% |
| Mar 31, 2021 | -13.85% |
| Dec 31, 2020 | -6.55% |
| Sep 30, 2020 | -17.47% |
| Jun 30, 2020 | -17.84% |
| Mar 31, 2020 | -17.64% |
| Dec 31, 2019 | -44.39% |
| Sep 30, 2019 | -16.29% |
| Jun 30, 2019 | -14.74% |
| Mar 31, 2019 | -13.93% |
| Dec 31, 2018 | -3.88% |
| Sep 30, 2018 | -2.90% |
| Jun 30, 2018 | 10.49% |
| Mar 31, 2018 | 11.05% |
| Dec 31, 2017 | 13.65% |
| Sep 30, 2017 | 25.25% |
| Jun 30, 2017 | 23.55% |
| Mar 31, 2017 | 10.83% |
| Dec 31, 2016 | 8.98% |
| Sep 30, 2016 | 4.00% |
| Jun 30, 2016 | -1.26% |
| Dec 31, 2015 | 8.87% |